Humedix Co., Ltd. engages in the manufacture and sale of various pharmaceutical products in South Korea. The company offers prescription medicines, active pharmaceutical ingredients, medical devices, cosmetics, and health functional food products. It is also involved in the manufacture and distribution of anticancer drugs. The company was formerly known as HVLS Co., Ltd. and changed its name to Humedix Co., Ltd. in 2010. Humedix Co., Ltd. was founded in 2002 and is headquartered in Seongnam-si, South Korea.
Frequently asked questions
What sector does Humedix Co Ltd (200670) operate in?
Humedix Co Ltd belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Humedix Co Ltd (200670) current stock price?
As of the latest data, Humedix Co Ltd stock price is ₩24,250, with a previous close of ₩24,650. Humedix Co Ltd lost -₩400 in the last trading session, representing a -1.62% loss.
What is Humedix Co Ltd (200670) current market capitalization?
Humedix Co Ltd market cap is approximately 269.23 billion.
Does Humedix Co Ltd (200670) pay dividends?
Yes. Humedix Co Ltd pays quarterly dividends with an annualized yield of 3.3% and an estimated annual payout of ₩800 per share.
When is the next ex-dividend date for Humedix Co Ltd (200670)?
The next ex-dividend date is scheduled for November 28, 2026.
What is Humedix Co Ltd (200670) beta (volatility) score?
Humedix Co Ltd has a beta of 0.348, indicating lower volatility than the overall market.